Bioequivalence and Bioavailability Forum

Main page Policy/Terms of Use Abbreviations Latest Posts

 Log-in |  Register |  Search

Back to the forum  Query: 2017-12-13 07:29 UTC (UTC+2h)
 
Ohlbe
Hero

France,
2017-07-25 16:52

Posting: # 17614
Views: 571
 

 Revised EMA guideline on first-in-human and early phase studies [Regulatives / Guidelines]

Dear all,

I know this is a bit far from bioequivalence trials, but we had some discussions on FIM here after the Bial trial accident.

The EMA has published today its revised guideline on strategies to identify and mitigate risks for first-in-human and early clinical trials with investigational medicinal products.

According to the associated press release, the overview of comments will be published in September.

Regards
Ohlbe
Back to the forum Activity
 Thread view
Bioequivalence and Bioavailability Forum | Admin contact
17,556 Posts in 3,758 Threads, 1,091 registered users;
29 users online (0 registered, 29 guests).

The purpose of models is not to fit the data,
but to sharpen the questions.    Samuel Karlin

The BIOEQUIVALENCE / BIOAVAILABILITY FORUM is hosted by
BEBAC Ing. Helmut Schütz
XHTML/CSS RSS Feed